1 / 15

EUROCHIP PILOT STUDIES IN POLAND

EUROCHIP PILOT STUDIES IN POLAND. Magdalena Bielska-Lasota and the Polish EUROCHIP WG. Varenna, October 2007. Conclusions from:. EUROCHIP - Domain Group of Care & Treatment – EUROCHIP Pilot Studies Brighton (UK), 15th February 2006.

matana
Télécharger la présentation

EUROCHIP PILOT STUDIES IN POLAND

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EUROCHIP PILOT STUDIES IN POLAND Magdalena Bielska-Lasota and thePolish EUROCHIP WG Varenna, October 2007

  2. Conclusions from: EUROCHIP - Domain Group of Care & Treatment – EUROCHIP Pilot Studies Brighton (UK), 15th February 2006 were presented at the Meeting of Polish Cancer Registries in Warsaw, 16th February 2006 Main problem: expected difficulties in organization and conducting population-based study on cancer treatment. That resulted in delay of starting the EUROCHIP Pilot Studies formally.

  3. Number of inhabitants in the regions covered by CRs participatingin EUROCHIP Pilot Studies Zatoński W. et al

  4. Cancer incidence /ASR/ in the regions covered by CRs participatingin EUROCHIP Pilot Studies http://85.128.14.124/krn

  5. Breast cancer patients Age distribution in Poland, and participating regions

  6. Colon and rectal cancers Age distribution in Poland and participating regions

  7. Number of cases collected for the Study and number of new cases in the regions

  8. Breast cancer patients. Age distribution in participating regions, and cases collected for the study

  9. Colon + rectal cancers Age distribution in participating regions and cases collected for the study

  10. Methods of data collection • Every 10-th patient recorded in population based CRs in Gliwice (Silesia voivodship) was selected and every 5-th recorded in Kielce (Holycross ) and Opole (Opolskie) • Clinical data were collected from: • Medical records of the patients treated or consulted in regional Cancer Center • Sometimes pathological laboratories were contacted • Patients treated in other hospitals: • - Gliwice - they called local hospitals by phone • - Kielce - CRs workers travelled themselves to the local hospitals • - Opole - medical records were sent from local hospitals to the CR upon request • Sometimes pathological laboratories were also contacted • If medical records were not available: • In Gliwice - they skipped and came to the next patient registered in CR (estimation was not done) • In Kielce - they skipped and came to the next 5-th registered patient (estimation: ca 8%) • In Opole - they skipped and came to the next 5-th registered patient (estimation: ca 10%)

  11. Difficulties in data collection • Limitation of CRs data in scope of data on diagnosis and treatment • Lack of unified system of data transferring between CRs and local hospitals treating cancer patients • Heterogeneous system in recording of medical procedures in various hospitals

  12. Final Remarks CRs in Gliwice, Kielce and Opole are convinced that having above experience they will be able to develop better collaboration with local hospitals in the next step of the study in order to minimise the selection biasand produce more accurate data. CRs in Gliwice, Kielce and Opole declare their wish to participate in the project in future, if it comes to its realization

  13. OTHER ACTIVITIES • Scientific publications: • Delays in treatment of breast and colorectal cancers in Holycross, Silesia and Opolskie woivodsips. Results of EUROCHIP pilot study in Poland. • Bielska-Lasota M, Czerw K, Góźdź S, Kołosza Z, Siudowska U, Rabczenko D, Zemła B and EUROCHIP WG. In preparation for Nowotwory J. Oncol. /Polish, abstract in English/ • Cancer indicators – the necessity for regular monitoring in Poland. • Bielska-Lasota M et al. In preparation for Nowotwory J. Oncol. /Polish, abstract in English/ • The reasons of poor results of cervical cancer treatment in Poland. • Bielska-Lasota M. Warszawa 2006. /Polish, abstract in English/ • Lecture: • Cancer as the health problem in Europe. Strategies for cancer control. • Bielska-Lasota M. National Institute of Hygiene. Scientific Committee Meeting. • 26 September 2007

  14. OTHER ACTIVITIES • Other: • Participation in public education activity and support of urological cancer patients group with the foundation – „Wygrajmy Zdrowie“(“Win the health”) • How can we fight cancer at the national level in Poland. • Skoneczna I, Bielska-Lasota M. and EUROCHIP WG [in:] Guide for the patients receiving chemotherapy. Michalski W. • Publication free of charge at the state of searching for the printing founder • http://www.wygrajmyzdrowie.pl/about-us.htm

More Related